Streptococcus pneumoniae response to repeated moxifloxacin or levofloxacin exposure in a rabbit tissue cage model

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 3, 2001, Pages 794-799

  Xuan, D ^a   Zhong, M ^a   Mattoes, H ^a   Bui, K Q ^a   McNabb, J ^a   Nicolau, D P ^a   Quintiliani, R ^a   Nightingale, C H ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN; MOXIFLOXACIN;

ABSCESS; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BACTERICIDAL ACTIVITY; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; DISEASE MODELS, ANIMAL; FEMALE; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; OFLOXACIN; PNEUMOCOCCAL INFECTIONS; QUINOLINES; RABBITS; STREPTOCOCCUS PNEUMONIAE;

EID: 0035111996     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.3.794-799.2001     Document Type: Article

References (14)

1. Comparison of the in vitro activities of BAY 12-8039 a new quinolone, and other antimicrobials against clinically important anaerobes
2. Comparison of the antimicrobial activities of the quinolones BAY gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin
3. In vitro activity of BAY12-8039, a new fluoroquinolone
4. Relative potential for selection of fluoroquinolone-resistant Streptococcus pneumoniae strains by levogfloxacin: Comparison with ciprofloxacin, sparfloxacin and ofloxacin
5. High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA
6. Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneztmoniae
7. Introduction: Disease management of pulmonary infections
8. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae
9. Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae
10. In vitro activity of BAY12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens
11. Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro
12. Antibiotic resistance in Streptococcus pneumoniae
13. Streptococcus pneumoniae resistance to fluoroquinolone